Differences

This shows you the differences between two versions of the page.

--- paxlovid [2022/02/03 22:08]
brian [In the News]
+++ paxlovid [2022/08/27 12:52] (current)
mathew
@@ Line 22: / Line 22: @@
 || NCT05129475 | Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants ||
 || NCT05064800 | PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants ||
+==== Press Releases ====
+On Friday, November 5, 2021, Pfizer issued a stunningly optimistic press release for a new drug, stating "overwhelming efficacy" and a risk reduction of 89% for hospitalization and death from COVID-19.((November 5, 2021 | Pfizer | [[https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate|Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study]])) The press release claimed that after 28 days there were 0 deaths in the treatment arm and 10 in the placebo arm, with 41 vs. 6 hospitalizations.
@@ Line 47: / Line 50: @@
 [[https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate|PFIZER’S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE REDUCED RISK OF HOSPITALIZATION OR DEATH BY 89% IN INTERIM ANALYSIS OF PHASE 2/3 EPIC-HR STUDY]] \\
 [[https://markets.businessinsider.com/news/stocks/pfizer-s-covid-19-franchise-could-push-revenue-past-100b-in-2022-analyst-1030999039|SVB Leerink analyst Geoffrey Porges forecasts Paxlovid revenues of $95 million in 2021, $24 billion in 2022, and $33 billion in 2023.]] \\
-[[https://www.pharmaceutical-technology.com/features/paxlovid-pfizer-covid-19-pill/ | Paxlovid: what we know about Pfizer’s Covid-19 pill]].
+[[https://www.pharmaceutical-technology.com/features/paxlovid-pfizer-covid-19-pill/ | Paxlovid: what we know about Pfizer’s Covid-19 pill]]. \\
 [[https://www.bloomberg.com/news/articles/2022-02-03/drug-maker-merck-s-antiviral-covid-pill-fumble-gives-pfizer-17-billion-win|Merck’s Covid Pill Fumble Gives Pfizer Potential $17 Billion Win]]
 ===== Sales =====